Literature DB >> 18331586

Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia.

George P Christophi1, Chad A Hudson, Ross Gruber, Christoforos P Christophi, Paul T Massa.   

Abstract

We have previously shown that the protein tyrosine phosphatase SHP-1 is highly expressed in CNS glia and is an important modulator of cytokine signaling. As such, mice genetically lacking SHP-1 display constitutive myelin abnormalities, severe virus-induced demyelinating disease, and defects in innate anti-viral responses in the CNS. In this study, we show the differential distribution of the SHP-1 promoter-specific transcripts and demonstrate that several cytokines significantly induce SHP-1 expression in CNS glia. Consistent with these cytokine effects, infection with a neurotropic virus both in vitro and in vivo up-regulates SHP-1 transcripts and protein in CNS cells. Using CNS glial cultures of gene knockout mice, we show that interferons-beta and interferons-gamma act through STAT-1 and interferon regulatory factor-1 to induce the SHP-1 promoter I transcripts. Conversely, interferons-beta and IL-6 act through STAT-3 to induce SHP-1 promoter II transcripts. This study demonstrates that interferons and other cytokines associated with virus infections in the CNS can significantly induce the expression of SHP-1 through STAT-1/3 activity and provides a better understanding of the molecular mechanisms regulating cytokine-induced expression important for multiple homeostatic functions of SHP-1 in the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331586      PMCID: PMC3422745          DOI: 10.1111/j.1471-4159.2008.05337.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

1.  Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis.

Authors:  Caishu Deng; Alfredo Minguela; Rehana Z Hussain; Amy E Lovett-Racke; Caius Radu; E Sally Ward; Michael K Racke
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements.

Authors:  Y Xu; D Banville; H F Zhao; X Zhao; S H Shen
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

3.  Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.

Authors:  Anna Yarilina; Edward DiCarlo; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors:  K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 5.  Therapeutic role of beta-interferons in multiple sclerosis.

Authors:  Adil Javed; Anthony T Reder
Journal:  Pharmacol Ther       Date:  2005-10-17       Impact factor: 12.310

6.  Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1.

Authors:  P T Massa; C Wu
Journal:  J Interferon Cytokine Res       Date:  1998-07       Impact factor: 2.607

7.  Defining interferon beta response status in multiple sclerosis patients.

Authors:  Richard A Rudick; Jar-Chi Lee; Jack Simon; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

8.  Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.

Authors:  Paul T Massa; Charlene Wu; Karen Fecenko-Tacka
Journal:  J Neurosci Res       Date:  2004-07-01       Impact factor: 4.164

9.  Induction of activator protein-1 and nuclear factor-kappaB as a prerequisite for disease development in susceptible SJL/J mice after theiler murine encephalomyelitis.

Authors:  Ingo Gerhauser; Reiner Ulrich; Susanne Alldinger; Wolfgang Baumgärtner
Journal:  J Neuropathol Exp Neurol       Date:  2007-09       Impact factor: 3.685

10.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  M David; H E Chen; S Goelz; A C Larner; B G Neel
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more
  12 in total

1.  B Cell-Intrinsic Expression of Interferon Regulatory Factor 1 Supports Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; K E Johnson; A A Uitenbroek; P A Sylvester; C Nguyen; W Cui; V L Tarakanova
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.

Authors:  George P Christophi; Ross C Gruber; Michael Panos; Rebecca L Christophi; Burk Jubelt; Paul T Massa
Journal:  Clin Immunol       Date:  2011-12-02       Impact factor: 3.969

3.  Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients.

Authors:  George P Christophi; Jennifer A Christophi; Ross C Gruber; Cornelia Mihai; Luis J Mejico; Paul T Massa; Burk Jubelt
Journal:  J Neurol Sci       Date:  2011-06-11       Impact factor: 3.181

4.  Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.

Authors:  Chiharu Kumagai; Bernadette Kalman; Frank A Middleton; Tamara Vyshkina; Paul T Massa
Journal:  J Neuroimmunol       Date:  2012-03-27       Impact factor: 3.478

5.  The control of reactive oxygen species production by SHP-1 in oligodendrocytes.

Authors:  Ross C Gruber; Daria LaRocca; Scott B Minchenberg; George P Christophi; Chad A Hudson; Alex K Ray; Bridget Shafit-Zagardo; Paul T Massa
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

6.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

7.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

8.  Cutting Edge: Dysregulated CARD9 Signaling in Neutrophils Drives Inflammation in a Mouse Model of Neutrophilic Dermatoses.

Authors:  Sarang Tartey; Prajwal Gurung; Parimal Samir; Amanda Burton; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2018-08-06       Impact factor: 5.422

9.  Downmodulation of Effector Functions in NK Cells upon Toxoplasma gondii Infection.

Authors:  M Afifa Sultana; Ann Du; Berit Carow; Catrine M Angbjär; Jessica M Weidner; Sachie Kanatani; Jonas M Fuks; Tamara Muliaditan; Jaime James; Imogen O Mansfield; Tessa M Campbell; Lifeng Liu; Nadir Kadri; Henrik Lambert; Antonio Barragan; Benedict J Chambers
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.